A. Sinclair Dunlop
CIK 1721108 · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
46
Lifetime Open-Market Net
-$28.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Director | 0 | $41.03 | $0 | -$28.11M | 46 | 2026-05-14 |
Recent Filings · Page 5 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-07 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −25,000 | -$1.26M | EDGAR |
| 2020-01-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −136,000 | -$3.96M | EDGAR |
| 2019-01-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-09 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Other (J) | +94,357 | $0 | EDGAR |
| 2017-11-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Conv (C) | +400,679 | $0 | EDGAR |
Showing 41–46 of 46
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.